Back
Laboratorios Farmaceúticos Rovi SA 10K Form
Sell
30
LABFF
Laboratorios Farmaceúticos Rovi SA
Last Price:
$65.86
Seasonality Move:
-7.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LABFF News And Ratings
See the #1 stock for the next 7 days that we like better than LABFF
LABFF Financial Statistics
Sales & Book Value
| Annual Sales: | $826.1M |
|---|---|
| Cash Flow: | $64.8M |
| Price / Cash Flow: | 28.55 |
| Annual Sales: | $14.28 |
| Price / Book: | 4.61 |
Profitability
| EPS (TTM): | 2.66570 |
|---|---|
| Net Income (TTM): | $136.3M |
| Gross Margin: | $486.4M |
| Return on Equity: | 20.71% |
| Return on Assets: | 14.13% |
Laboratorios Farmaceúticos Rovi SA Earnings Forecast
Key Laboratorios Farmaceúticos Rovi SA Financial Ratios
-
The Gross Profit Margin over the past 20 years for LABFF is 58.88%.
-
The Selling, General & Administrative Expenses for LABFF have been equal to 30.93% of Gross Profit Margin.
-
The Research & Development expenses have been 3.37% of Revenue.
-
The Interest Expense is 1.72% of Operating Income.
-
The Net Earning history of LABFF is 17.92% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 13 years.
Laboratorios Farmaceúticos Rovi SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LABFF |
| Website: | rovi.es |
Debt
| Debt-to-Equity Ratio: | 0.2 |
|---|---|
| Current Ratio: | 3.02 |
| Quick Ratio: | 1.3 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.75 |
|---|---|
| Forward P/E Ratio: | 0 |
LABFF Technical Analysis vs Fundamental Analysis
Sell
30
Laboratorios Farmaceúticos Rovi SA (LABFF)
is a Sell
Is Laboratorios Farmaceúticos Rovi SA a Buy or a Sell?
-
Laboratorios Farmaceúticos Rovi SA stock is rated a SellThe current Laboratorios Farmaceúticos Rovi SA [LABFF] share price is $65.86. The Score for LABFF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.